Clinical Trial Update: Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents [Phase 3]

View source ↗

Summary

Phase 3 safety study of sodium divalproate in adolescents with bipolar disorder has completed (sponsor: Sanofi).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Sodium divalproate (divalproate)

Snippet

Sponsor: Sanofi | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED